Korecyte Bio
PrivateLast Round
Seed
May 26, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Korecyte Bio is a biotechnology company that develops next-generation CAR-T cellular immunotherapies for the treatment of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Korecyte Bio Comparables
Compare Korecyte Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Leucid Bio | 85% | |
| CREATE Medicines | 71% | |
| AstraZeneca | 71% |
Korecyte Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 26, 2026 | ||||
| Grant | Aug 27, 2024 |
Korecyte Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cell and Gene Therapy Catapult | Seed |
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 672% MoM, reaching 1.2K.
- Aug 27, 2024
Received grant funding from Innovate UK.
Korecyte Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Korecyte Bio's valuation, stock price, and market status.
Is Korecyte Bio a public or private company?
Korecyte Bio is a private company.
What is the current stock price of Korecyte Bio?
Korecyte Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Korecyte Bio worth (valuation)?
Valuation information for Korecyte Bio is not publicly available.
Can I buy Korecyte Bio stock?
Korecyte Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Korecyte Bio's last funding round?
Korecyte Bio's most recent funding round was Seed on May 26, 2026.
Who are the main investors in Korecyte Bio?
Key investors in Korecyte Bio include Cell and Gene Therapy Catapult, Innovate UK.
Will Korecyte Bio IPO soon?
No public IPO plans have been announced for Korecyte Bio.
How can I track Korecyte Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Korecyte Bio's secondary market activity and sign up for updates.